Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
154.1%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 24.21Close
$ 11.02 - $ 25.71 52-Week Range
Ticker Information
Ticker
VRDNCompany Name
VIRIDIAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVIRIDIAN THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VRDN - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 470K | 154.1% | $ 305K |
| 3/31/2025 | $ 693K | 229.47% | $ 302K |
| 12/31/2024 | $ 711K | 235.43% | $ 302K |
| 9/30/2024 | $ 744K | 246.36% | $ 302K |
| 6/30/2024 | $ 811K | 281.6% | $ 288K |
| 3/31/2024 | $ 582K | 202.08% | $ 288K |
| 12/31/2023 | $ 570K | 181.53% | $ 314K |
| 9/30/2023 | $ 523K | 150.72% | $ 347K |
| 6/30/2023 | $ 363K | 24.69% | $ 1.47M |
| 3/31/2023 | $ 368K | 22.25% | $ 1.65M |
Key Performance Insights, Last 5 Years
- VIRIDIAN THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 13.97%.
- Over the past 5 years, VIRIDIAN THERAPEUTICS INC's average DepAmor % has been 91.25%.
- The median DepAmor % for VIRIDIAN THERAPEUTICS INC during this period was 22.51%
- VIRIDIAN THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 281.6%.
- The lowest DepAmor % recorded by VIRIDIAN THERAPEUTICS INC in the same timeframe 0.61%
VIRIDIAN THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for VIRIDIAN THERAPEUTICS INC is calculated as follows: DepAmor [ $ 262K ] / Revenues [ $ 1.88M ]
(=) DepAmor % [ 13.97% ] VRDN - Depreciation and Amortization Margin, Last 5 years
0.61%
Minimum
Dec 31, 2021
281.6%
Maximum
Jun 30, 2024
91.25%
Average
22.51%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |